Overview
Myeloma cells are malignant plasma cells that proliferate clonally within the bone marrow and give rise to multiple myeloma, a cancer of the terminally differentiated B-lymphocyte lineage. Derived from a single transformed plasma cell, they typically secrete a monoclonal immunoglobulin or free light chain, the paraprotein detectable in serum or urine, and depend on supportive interactions with the marrow microenvironment for survival and expansion. Their accumulation suppresses normal haematopoiesis and disrupts bone homeostasis, producing the characteristic features of anaemia, osteolytic bone disease and pathological fracture, hypercalcaemia, renal impairment, and susceptibility to infection. Myeloma cells are genomically heterogeneous, harbouring recurrent chromosomal translocations, copy-number changes, and subclonal evolution that drive disease progression and treatment resistance. Related plasma cell disorders illustrate the spectrum of this biology, including extramedullary and extraosseous plasmacytoma, plasma cell pleocytosis, and the lymphoplasmacytic proliferation of Waldenström's macroglobulinaemia. Research on myeloma cells addresses their pathogenesis, the mobilisation and collection of autologous stem cells for transplantation, complications of marrow involvement, and the development of targeted, immunomodulatory, and immune-based therapies. Characterising the molecular dependencies and microenvironmental signals that sustain myeloma cells remains central to improving diagnosis, risk stratification, and durable disease control in this incurable but increasingly treatable malignancy.
Research published in this journal
6 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Extraosseous Plasmacytoma of Thyroid Arising in Hashimoto’s Thyroiditis
An Uncommon Complication of Multiple Myeloma in a Post Bone Marrow Transplant patient–Plasma Cell Pleocytosis
Itraconazole Prophylaxis for an Outbreak of Invasive Aspergillosis in a Hematology Ward after Hospital Construction Work
The Daughter of Time: Late Development of Waldenstrom’s Macroglobulinemiain a Patient with Immunotactoid Glomerulopathy.
Presentation of Neutralizing Antibodies in Single- or Pooled-Convalescent Immune Plasma from Donors to Prevent the Current SARS-CoV-2 Pandemic
How this research is being cited
The 6 articles above have been cited 9 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2022 · Head and Neck Pathology
-
2022 · Head and Neck Pathology
-
Wolfgang Neukirchen et al. · 2022 · Case Reports in Nephrology and Dialysis
-
2021 ·
-
2021 · SN Computer Science
-
2020 · Clinical Case Reports
-
2020 ·
-
Xin Qian et al. · 2020 · CHI Extended Abstracts
A sample of recent works citing this journal's research on Myeloma Cells, linking to each citing work.